New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxep ines

Details for Australian Patent Application No. 2005235671 (hide)

Owner Merck Patent GmbH

Inventors Boudet, Bernard; Saleh, Twana

Agent Davies Collison Cave

Pub. Number AU-B-2005235671

PCT Pub. Number WO2005/102977

Priority 04291091.9 27.04.04 EP

Filing date 5 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 17 March 2011

International Classifications

C07C 43/313 (2006.01) Ethers

C07C 43/315 (2006.01) Ethers

C07C 309/66 (2006.01) Sulfonic acids

C07D 313/08 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

C07D 317/22 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/102977 Priority application(s): WO2005/102977

17 March 2011 Application Accepted

  Published as AU-B-2005235671

14 July 2011 Standard Patent Sealed

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235679-Novel piperidine substituted diaminothiazoles

2005235669-Recombinant polypeptides of the members of the TNF ligand family and use thereof